BCL6

 B-cell lymphoma 6 protein is a protein that in humans is encoded by the BCL6 gene.[5] Like BCL2, BCL3, BCL5, BCL7A, BCL9 and BCL10, it has clinical significance in lymphoma.

BCL6
Protein BCL6 PDB 1r28.png
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesBCL6, BCL5, BCL6A, LAZ3, ZBTB27, ZNF51, B-cell CLL/lymphoma 6, B cell CLL/lymphoma 6, transcription repressor, BCL6 transcription repressor
External IDsOMIM109565 MGI107187 HomoloGene7640 GeneCardsBCL6
Gene location (Human)
Chromosome 3 (human)
Chr.Chromosome 3 (human)[1]
Chromosome 3 (human)
Genomic location for BCL6
Genomic location for BCL6
Band3q27.3Start187,721,377 bp[1]
End187,745,725 bp[1]
RNA expression pattern
PBB GE BCL6 215990 s at fs.png

PBB GE BCL6 203140 at fs.png
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001130845
NM_001134738
NM_001706
NM_138931

NM_009744
NM_001348026

RefSeq (protein)

NP_001124317
NP_001128210
NP_001697

NP_001334955
NP_033874

Location (UCSC)Chr 3: 187.72 – 187.75 MbChr 16: 23.97 – 23.99 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

FunctionEdit

The protein encoded by this gene is an evolutionarily conserved zinc finger transcription factor and contains an N-terminal POZ/BTB domain. This protein acts as a sequence-specific repressor of transcription and has been shown to modulate the STAT-dependent Interleukin 4 (IL-4) responses of B cells. This protein can interact with several corepressor complexes to inhibit transcription. This gene is found to be frequently translocated and hypermutated in diffuse large B cell lymphoma (DLBCL)[6][7][8] and contributes to the pathogenesis of DLBCL. An exon 7 skipping splice variant encodes a shorter form of the protein which lacks the first two zinc fingers of the DNA binding domain.[9]

Physiologically, BCL6 is a master transcription factor which leads the differentiation of naive helper T cells in Follicular Helper T cells (TFH cells).[10] Its action is negatively regulated by the gene PRDM1 encoding the transcription factor Blimp-1.[11]

Diagnostic utilityEdit

The presence of BCL6 can be demonstrated in tissue sections using immunohistochemistry. It is exclusively present in the B-cells of both healthy and neoplastic germinal centres. It therefore demonstrates both reactive hyperplasia in lymph nodes and a range of lymphomas derived from follicular B-cells, such as Burkitt's lymphomafollicular lymphoma and the nodular lymphocyte predominant subtype of Hodgkin's disease. It is often used together with antibodies to Bcl-2 antigen to distinguish neoplastic follicles from those found in benign hyperplasia, for which Bcl-2 is negative.[12]

This article uses material from the Wikipedia article
 Metasyntactic variable, which is released under the 
Creative Commons
Attribution-ShareAlike 3.0 Unported License
.